Pediatric Vaccine Market - By Vaccine Type (Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated, Toxoid, Conjugate), By Application (Infectious Disease, Allergy, Cancer) And By Region, Opportunities And Strategies – Global Forecast To 2030

Starting Price : $5000.00 | Pages : 226 | Published : August 2021 | SKU CODE : o&s302 | Format :

Request Sample

Pediatric Vaccine Market Definition

The pediatric vaccine market consists of sales of pediatric vaccines and related services used to provide immunity to infants and children from birth to 18 years of age for specific diseases. Pediatric vaccines are a preparation of dead microorganisms, live attenuated organisms, or fully virulent organisms that are administered to stimulate the production of antibodies and provide immunity against one or several diseases among children. Pediatric vaccines are used in childhood immunization schedules to enhance a child’s immunity or prevent diseases such as diphtheria, tetanus, pertussis, influenza, Hepatitis B, polio, and many other infectious and non-infectious diseases.

The market by value in this report is defined as the revenues that enterprises gain from goods and/or services within the specified market and geography. It does not include revenues from resales of goods and services such as media rights, and merchandise either further along the supply chain or as part of other products. Only goods and services traded between entities or sold to end consumers are included. Whether specifically stated or not, the markets for goods include related services and the markets for services include related goods.

Pediatric Vaccine Market Size

The global pediatric vaccine market reached a value of nearly $34,094.8 million in 2020, having increased at a compound annual growth rate (CAGR) of 6.8% since 2015. The market is expected to grow from $34,094.8 million in 2020 to $58,130.0 million in 2025 at a rate of 11.3%. The pediatric vaccine market is then expected to grow at a CAGR of 9.1% from 2025 and reach $90,000.9 million in 2030.

Growth in the historic period resulted from increased prevalence of chronic diseases, immunization policies to eradicate endemic diseases, increased funding for vaccine development. Factors that negatively affected growth in the historic period were long vaccine development and manufacturing timelines, high cost associated with vaccine doses.

Going forward, increasing cases of invasive cervical cancer, strong late-stage pipeline and new drug approvals, increasing prevalence of infectious diseases will drive growth. Factors that could hinder the growth of the market in the future include vaccine refusal by parents, skilled workforce shortages, stringent regulations related to pediatric vaccines approvals.

Pediatric Vaccine Market Drivers

The key drivers of the pediatric vaccine market include:

Increasing Prevalence Of Infectious Diseases

The prevalence of infectious diseases is high in the pediatric population, as the immune system of children is not fully developed. Common infections in children include influenza, hepatitis, chickenpox, pertussis, RSV, and roseola. The growing prevalence of infectious diseases is also attributed to the rising population and environmental and genetic factors. For instance, every year, influenza epidemics result in about 870,000 children under 5?years of age leads to hospitalization. Thus, the increasing prevalence of infectious diseases in the pediatric population will increase the demand for pediatric vaccines during the forecast period.

Pediatric Vaccine Market Restraints

The key restraints on the pediatric vaccine market include:

Stringent Regulations Related To Pediatric Vaccines Approvals

Stringent regulations imposed on approval of pediatric vaccines are anticipated to hinder the growth of the market in the forecast period. Governments of different regions impose different rules regarding the production and use of vaccines. For instance, the vaccine-approval process in the US is regulated by the US Food and Drug Administration. Throughout the life cycle of development, from preclinical studies to after licensure, vaccines are subject to rigorous testing and oversight. Manufacturers must adhere to good manufacturing practices and control procedures to ensure the quality of vaccines. As mandated by Title 21 of the Code of Regulations, licensed vaccines must meet stringent criteria for safety, efficacy, and potency. The robust government policies for approval of these vaccines negatively impact manufacturers in the pediatric vaccine market.

Pediatric Vaccine Market Trends

Major trends influencing the pediatric vaccine market include:

Development Of Combination Vaccines

There has been increasing demand for combination vaccines among babies. Combination vaccines are a combination of multiple vaccines into one. The benefits of such vaccines apply for both the parents and the baby. The parents have fewer visits to doctor, less hassle, cost effective and time effective. The babies have to take fewer shots implying less pain and discomfort. Many companies have started developing combination vaccines as the demand increased. For instance, in October 2020, Merck and Sanofi Pasteur a U.S.-based joint-partnership vaccine company developed, manufactured and marketed, VAXELIS, a combination vaccine for Diphtheria and Tetanus Toxoids and Acellular Pertussis, Inactivated Poliovirus, Haemophilus b Conjugate and Hepatitis B.

Increase In Live Attenuated Vaccines

The focus area for many companies in the pediatric vaccine market has shifted to increasing popularity of live vaccines. Live vaccines use a weakened form of germ that causes a disease and creates a strong and long-lasting immune response. These vaccines are also more durable and allows the body to retain its immune memory of a pathogen for a longer period of time. These vaccines do not always require a booster shot and are hence, witnessing an increase in popularity. For example, a live attenuated hepatitis A vaccine may be protective for 20 years or more.  

Opportunities And Recommendations In The Pediatric Vaccine Market

Opportunities – The top opportunities in the pediatric vaccine market segmented by vaccine type will arise in monovalent market, which will gain $18,993.1 million of global annual sales by 2025. The top opportunities in the pediatric vaccine market segmented by technology will arise in the conjugate market, which will gain $10,684.6 million of global annual sales by 2025. The top opportunities in the pediatric vaccine market segmented application will arise in infectious disease market, which will gain $21,690.7 million of global annual sales by 2025. The pediatric vaccine market size will gain the most in the USA at $8,622.8 million.

Recommendations – To take advantage of these opportunities, The Business Research Company recommends the pediatric vaccine companies to focus on investing in the development of combination vaccines, COVID-19 vaccine for kids, ribonucleic acid (RNA) vaccines, expand in low- and middle-income regions, and geographies with government vaccination funding, provide competitive pricing, targeting hospital and pediatric practitioners to spread awareness, and spreading awareness among parents.

Pediatric Vaccine Market Segmentation

The pediatric vaccine market is segmented by vaccine type, by technology, by application, and by geography.
By Vaccine Type –
The pediatric vaccine market is segmented by vaccine type into
    • a) Monovalent
    • b) Multivalent
The monovalent market was the largest segment of the pediatric vaccine market segmented by vaccine type, accounting for 76.8% of the total in 2020. Going forward, the multivalent market segment is expected to be the fastest growing segment in the pediatric vaccine market segmented by vaccine type, at a CAGR of 10.4% during 2020-2025.
By Technology –
The pediatric vaccine market is segmented by technology into
    • a) Conjugate
    • b) Live Attenuated
    • c) Inactivated
    • d) Toxoid
    • e) Other Technologies
The conjugate technology market was the largest segment of the pediatric vaccine market segmented by technology, accounting for 40.8% of the total in 2020. Going forward, the conjugate market segment is expected to be the fastest growing segment in the pediatric vaccine market segmented by technology, at a CAGR of 12.1% during 2020-2025.
By Application –
The pediatric vaccine market is segmented by application into
    • a) Infectious Disease
    • b) Cancer
    • c) Allergy
The infectious disease market was the largest segment of the pediatric vaccine market segmented by application, accounting for 89.3% of the total in 2020. Going forward, the infectious disease market segment is expected to be the fastest growing segment in the pediatric vaccine market segmented by application, at a CAGR of 8.0% during 2020-2025.
By Geography-
The pediatric vaccine market is segmented by geography into
    • o Asia Pacific
      • •  China
      • •  Japan
      • •  India
      • •  Australia
      • •  Indonesia
      • •  South Korea
    • o North America
      • • USA
      o South America
      • • Brazil 
      o Western Europe
      • • UK 
      • • Germany 
      • • France 
      o Eastern Europe
      • • Russia 
      o Middle East
      o Africa
North America was the largest region in the pediatric vaccine market, accounting for 37.6% of the total in 2020. It was followed by the Asia-Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the pediatric vaccine market will be Asia-Pacific and North America where growth will be at CAGRs of 13.6% and 11.7% respectively during 2020-2025. These will be followed by the Middle East and Western Europe, where the markets are expected to register CAGRs of 9.4% and 9.2% respectively during 2020-2025.

Pediatric Vaccine Competitive Landscape

Major Competitors In The Pediatric Vaccine Market Are:

  • Merck & Co Inc
  • Serum Institute of India Pvt. Ltd
  • Sanofi SA
  • Pfizer
  • AstraZeneca
  • Other Competitors In The Pediatric Vaccine Market Include:

  • GlaxoSmithKline PLC
  • Sinovac Biotech Ltd
  • Zydus Cadila
  • Indian Immunologicals Limited
  • Panacea Biotec
  • Takeda Pharmaceutical Company
  • Mitsubishi Tanabe Pharma Corporation
  • Daiichi Sankyo
  • CSL Limited
  • BIO-MED
  • Sun Pharmaceutical Industries Ltd
  • Sinopharm
  • Walvax biotechnology
  • Fosun Pharma
  • BioNTech
  • MCM Vaccine Company
  • Seqirus
  • Roche
  • Johnson & Johnson
  • Novartis
  • Connaught Laboratories Inc.
  • Wyeth-Ayerst
  • Grifols
  • Ataulfo de Paiva Foundation
  • Bio-Manguinhos–Institute of Technology on Immunobiologicals
  • Butantan Institute
  • Ezequiel Dias Foundation (FUNED)
  • National Administration of Laboratories
  • Institutes of Health ANLIS Dr. Carlos G. Malbrán
  • Sinergium
  • Biovac Institute
    1. Table Of Contents

      1. Pediatric Vaccine Market Executive Summary

      2. Table of Contents

      3. List of Figures

      4. List of Tables

      5. Report Structure

      6. Introduction

      6.1.1.Segmentation By Geography

      6.1.2. Segmentation By Vaccine Type

      6.1.3.Segmentation By Technology

      6.1.4. Segmentation By Application

      7. Pediatric Vaccine Market Characteristics

      7.1. Market Definition

      7.2. Market Segmentation By Vaccine Type

      7.2.1. Monovalent

      7.2.2.Multivalent

      7.3. Market Segmentation By Technology

      7.3.1. Live Attenuated

      7.3.2. Inactivated

      7.3.3. Toxoid

      7.3.4. Conjugate

      7.3.5. Other Technologies

      7.4. Market Segmentation By Application

      7.4.1. Infectious Disease

      7.4.2.Allergy

      7.4.3. Cancer

      8. Pediatric Vaccine Market Trends And Strategies

      8.1. Development Of Combination Vaccines

      8.2. COVID-19 Vaccine For Kids

      8.3. Robust Research And Development

      8.4. Increase In Live Attenuated Vaccines

      8.5. Immunoengineering And Advanced Delivery Systems

      8.6. Increase In Conjugate Vaccines

      8.7. Artificial Intelligence In Vaccine Development

      9. Impact Of COVID-19 On The Pediatric Vaccine Market

      9.1. Introduction

      9.2. Decline In Pediatric Vaccinations

      9.3. COVID-19 Vaccines For Children

      9.4. Future Outlook

      10. Global Pediatric Vaccine Market Size And Growth

      10.1. Market Size

      10.2. Historic Market Growth, 2015 – 2020, Value ($ Million)

      10.2.1. Drivers Of The Market 2015 – 2020

      10.2.2. Restraints On The Market 2015 – 2020

      10.3. Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      10.3.1. Drivers Of The Market 2021 – 2025

      10.3.2. Restraints On The Market 2020 – 2025

      11. Global Pediatric Vaccine Market Segmentation

      11.1.Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.1.1. Monovalent

      11.1.2. Multivalent

      11.2. Global Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.2.1. Conjugate

      11.2.2. Live Attenuated

      11.2.3. Inactivated

      11.2.4. Toxoid

      11.2.5. Other Technologies

      11.3.Global Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      11.3.1. Infectious Disease

      11.3.2. Cancer

      11.3.3. Allergy

      12. Pediatric Vaccine Market, Regional And Country Analysis

      12.1. Global Pediatric Vaccine Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      12.2. Global Pediatric Vaccine Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13. Asia-Pacific Pediatric Vaccine Market

      13.1.Asia-Pacific Pediatric Vaccine Market Overview

      13.1.1. Region Information

      13.1.2. Market Information

      13.1.3. COVID-19 Impact

      13.1.4. Background Information

      13.1.5. Government Initiatives

      13.1.6. Regulations

      13.1.7.  Regulatory Bodies

      13.1.8. Major Associations

      13.1.9. Investments

      13.1.10. Taxes Levied

      13.1.11. Corporate Tax Structure

      13.1.12. Major Companies

      13.2. Asia-Pacific Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.3.Asia-Pacific Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.4. Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.5.Asia-Pacific Pediatric Vaccine Market: Country Analysis

      13.6. China Pediatric Vaccine Market

      13.7. China Pediatric Vaccine Market Overview

      13.7.1.  Country Information

      13.7.2. Market Information

      13.7.3.  COVID-19 Impact

      13.7.4. Background Information

      13.7.5.  Government Initiatives

      13.7.6. Regulations

      13.7.7.  Regulatory Bodies

      13.7.8. Major Associations

      13.7.9. Investments

      13.7.10. Taxes Levied

      13.7.11. Corporate Tax Structure

      13.7.12. Major Companies

      13.8. China Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.9. China Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.10.  China Pediatric Vaccine Market, Segmentation ByVaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.11.  India Pediatric Vaccine Market

      13.12.  India Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.13.  India Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.14.  India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.15.  Japan Pediatric Vaccine Market

      13.16.  Japan Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.17.   Japan Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.18.  Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.19.  Australia Pediatric Vaccine Market

      13.20. Australia Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.21.  Australia Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.22. Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.23.  Indonesia Pediatric Vaccine Market

      13.24. Indonesia Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.25.  Indonesia Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.26. Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      13.27.  South Korea Pediatric Vaccine Market

      13.28. South Korea Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      13.29. South Korea Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      13.30.  South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14. Western Europe Pediatric Vaccine Market

      14.1. Western Europe Pediatric Vaccine Market Overview

      14.1.1. Region Information

      14.1.2. Market Information

      14.1.3. COVID-19 Impact

      14.1.4. Background Information

      14.1.5. Government Initiatives

      14.1.6. Regulations

      14.1.7. Regulatory Bodies

      14.1.8. Major Associations

      14.1.9. Taxes Levied

      14.1.10. Corporate Tax Structure

      14.1.11. Investments

      14.1.12. Major Companies

      14.2. Western Europe Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.3. Western Europe Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.4. Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.5. Western Europe Pediatric Vaccine Market: Country Analysis

      14.6. UK Pediatric Vaccine Market

      14.7.UK Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.8. UK Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.9. UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.10. Germany Pediatric Vaccine Market

      14.11.  Germany Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.12. Germany Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.13.  Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      14.14. France Pediatric Vaccine Market

      14.15.  France Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      14.16. France Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      14.17.  France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15. Eastern Europe Pediatric Vaccine Market

      15.1.Eastern Europe Pediatric Vaccine Market Overview

      15.1.1. Region Information

      15.1.2. Market Information

      15.1.3. COVID-19 Impact

      15.1.4. Background Information

      15.1.5. Government Initiatives

      15.1.6. Regulations

      15.1.7.  Regulatory Bodies

      15.1.8. Major Associations

      15.1.9. Investments

      15.1.10. Taxes Levied

      15.1.11. Corporate Tax Structure

      15.1.12. Major Companies

      15.2. Eastern Europe Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.3.Eastern Europe Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.4. Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      15.5.Eastern Europe Pediatric Vaccine Market: Country Analysis

      15.6. Russia Pediatric Vaccine Market

      15.7. Russia Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      15.8. Russia Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      15.9. Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16. North America Pediatric Vaccine Market

      16.1. North America Pediatric Vaccine Market Overview

      16.1.1. Region Information

      16.1.2. Market Information

      16.1.3. COVID-19 Impact

      16.1.4. Background Information

      16.1.5. Government Initiatives

      16.1.6. Regulations

      16.1.7. Regulatory Bodies

      16.1.8. Major Associations

      16.1.9. Taxes Levied

      16.1.10. Investments

      16.1.11. Major Companies

      16.2. North America Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.3. North America Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.4. North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      16.5. North America Pediatric Vaccine Market: Country Analysis

      16.6. USA Pediatric Vaccine Market

      16.7.USA Pediatric Vaccine Market Overview

      16.7.1. Country Information

      16.7.2. Market Information

      16.7.3. COVID-19 Impact

      16.7.4. Background Information

      16.7.5. Government Initiatives

      16.7.6. Regulations

      16.7.7.  Regulatory Bodies

      16.7.8. Major Associations

      16.7.9. Taxes Levied

      16.7.10. Investments

      16.7.11. Major Companies

      16.8. USA Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      16.9. USA Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      16.10. USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17. South America Pediatric Vaccine Market

      17.1. South America Pediatric Vaccine Market Overview

      17.1.1.  Region Information

      17.1.2. Market Information

      17.1.3.  Impact of COVID-19

      17.1.4. Background Information

      17.1.5.  Government Initiatives

      17.1.6. Regulatory Bodies

      17.1.7.  Regulations

      17.1.8. Major Associations

      17.1.9. Taxes Levied

      17.1.10. Corporate Tax Structure

      17.1.11. Investments

      17.1.12. Major Companies

      17.2.South America Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.3. South America Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.4.South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      17.5. South America Pediatric Vaccine Market: Country Analysis

      17.6.Brazil Pediatric Vaccine Market

      17.7. Brazil Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      17.8.Brazil Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      17.9.Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      18. Middle East Pediatric Vaccine Market

      18.1. Middle East Pediatric Vaccine Market Overview

      18.1.1. Region Information

      18.1.2. Market Information

      18.1.3. Impact of COVID-19

      18.1.4. Background Information

      18.1.5. Government Initiatives

      18.1.6. Regulatory Bodies

      18.1.7. Regulations

      18.1.8. Major Associations

      18.1.9. Taxes Levied

      18.1.10. Corporate Tax Structure

      18.1.11. Investments

      18.1.12. Major Companies

      18.2. Middle East Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      18.3. Middle East Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      18.4. Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      19. Africa Pediatric Vaccine Market

      19.1. Africa Pediatric Vaccine Market Overview

      19.1.1. Region Information

      19.1.2. Market Information

      19.1.3. COVID-19 Impact

      19.1.4. Background Information

      19.1.5. Government Initiatives

      19.1.6. Regulations

      19.1.7. Regulatory Bodies

      19.1.8. Major Associations

      19.1.9. Taxes Levied

      19.1.10. Corporate Tax Structure

      19.1.11. Investments

      19.1.12. Major Companies

      19.2. Africa Pediatric Vaccine Market, Historic Market Growth, 2015 – 2020, Value ($ Million)

      19.3. Africa Pediatric Vaccine Market, Forecast Market Growth, 2020 – 2025, 2030F, Value ($ Million)

      19.4. Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, Value ($ Million)

      20.  Global Pediatric Vaccine Market Competitive Landscape

      20.1. Company Profiles

      20.2. Merck & Co. Inc.

      20.2.1. Company Overview

      20.2.2.  Products And Services

      20.2.3. Business Strategy

      20.2.4.  Financial Overview

      20.3. Serum Institute of India Pvt. Ltd.

      20.3.1. Company Overview

      20.3.2. Products And Services

      20.3.3. Business Strategy

      20.3.4. Financial Overview

      20.4. Sanofi SA

      20.4.1. Company Overview

      20.4.2.  Products And Services

      20.4.3. Business Strategy

      20.4.4.  Financial Overview

      20.5. Pfizer

      20.5.1. Company Overview

      20.5.2. Products And Services

      20.5.3. Business Strategy

      20.5.4. Financial Overview

      20.6. AstraZeneca

      20.6.1. Company Overview

      20.6.2.  Products And Services

      20.6.3. Business Strategy

      20.6.4.  Financial Overview

      21. Pediatric Vaccine Market, Product Pipeline Analysis

      22.  Key Mergers And Acquisitions In The Pediatric Vaccine Market

      22.1. Sanofi S.A. Acquired Kymab Ltd

      22.2. Johnson & Johnson Acquired Momenta Pharmaceuticals, Inc.

      22.3. AbbVie Inc. Acquired Allergan plc

      22.4. Gilead Sciences Inc. Acquired Forty Seven, Inc.

      22.5. WuXi Biologics Acquired Drug Product Manufacturing Plant From Bayer

      22.6. Bristol-Myers Squibb Acquired Celgene

      22.7. Takeda Pharmaceutical Company Limited Acquired Shire plc

      22.8. GlaxoSmithKline plc Acquired Tesaro, Inc.

      22.9. Sanofi S.A. Acquired Bioverativ Inc.

      23. Pediatric Vaccine Market Opportunities And Strategies

      23.1. Global Pediatric Vaccine Market In 2025 – Countries Offering Most New Opportunities

      23.2. Global Pediatric Vaccine Market In 2025 – Segments Offering Most New Opportunities

      23.3. Global Pediatric Vaccine Market In 2025 – Growth Strategies

      23.3.1. Market Trend Based Strategies

      23.3.2. Competitor Strategies

      24.  Pediatric Vaccines Market, Conclusions And Recommendations

      24.1. Conclusions

      24.2. Recommendations

      24.2.1. Product

      24.2.2.  Place

      24.2.3. Price

      24.2.4.  Promotion

      25. Appendix

      25.1. Market Data Sources

      25.2. Research Methodology

      25.3. Currencies

      25.4. Research Inquiries

      25.5. The Business Research Company

      25.6. Copyright and Disclaimer

    List Of Tables

      Table 1: Global Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 2: Global Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 3: Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 4: Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 5: Global Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 6: Global Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 7: Global Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 8: Global Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 9: Global Pediatric Vaccine Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 10: Global Pediatric Vaccine Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 11: Global Pediatric Vaccine Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 12: Global Pediatric Vaccine Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 13: Asia Pacific GDP Per Capita, 2015-2020, $
    • Table 14: Asia Pacific, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 15: Asia-Pacific Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 16:  Asia-Pacific Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 17: Asia-Pacific Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 18: Asia-Pacific Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 19: Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 20: Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 21: China GDP Per Capita, 2015-2020, $
    • Table 22: China, Population By Age Group, 2015-2023, Thousands
    • Table 23:  China Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 24: China Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 25: China Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 26: China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 27: China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 28: India Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 29: India Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 30: India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 31: India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 32: Japan Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 33: Japan Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 34: Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 35: Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 36: Australia Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 37: Australia Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 38: Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 39: Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 40: Indonesia Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 41: Indonesia Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 42: Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 43: Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 44: South Korea Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 45: South Korea Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 46: South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 47: South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 48: Western Europe GDP Per Capita, 2015-2020, $
    • Table 49: Western Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 50:  Western Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 51:  Western Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 52: Western Europe Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 53: Western Europe Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 54: Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 55: Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 56: UK Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 57: UK Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 58: UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 59: UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 60: Germany Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 61: Germany Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 62: Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 63: Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 64: France Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 65: France Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 66: France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 67: France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 68: Eastern Europe GDP Per Capita, 2015-2020, $
    • Table 69: Eastern Europe, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 70:  Eastern Europe Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 71:  Eastern Europe Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 72: Eastern Europe Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 73: Eastern Europe Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 74: Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 75: Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 76: Russia Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 77: Russia Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 78: Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 79: Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 80: North America GDP Per Capita, 2015-2020, $
    • Table 81: North America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 82:  North America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 83:  North America Private Healthcare Expenditure, 2013-2017, $ Billion
    • Table 84: North America Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 85: North America Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 86: North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 87: North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 88: USA GDP Per Capita, 2015-2020, $
    • Table 89: USA, Population By Age Group, 2015-2023, Thousands
    • Table 90:  USA Public Healthcare Expenditure And Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 91: USA Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 92: USA Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 93: USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 94: USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 95: South America GDP Per Capita, 2015-2020, $
    • Table 96: South America, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 97:  South America Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 98:  South America Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 99: South America Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 100: South America Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 101: South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 102: South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 103: Brazil Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 104: Brazil Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 105: Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 106: Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 107: Middle East GDP Per Capita, 2015-2020, $
    • Table 108: Middle East, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 109:  Middle East Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 110:  Middle East Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 111: Middle East Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 112: Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 113: Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 114: Africa GDP Per Capita, 2015-2020, $
    • Table 115: Africa, Population By Age Group, By Country, 2015-2023, Thousands
    • Table 116: Africa Public Healthcare Expenditure, 2015-2019, $ Billion
    • Table 117: Africa Private Healthcare Expenditure, 2015-2019, $ Billion
    • Table 118: Africa Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Table 119: Africa Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Table 120: Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Table 121: Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, $ Million
    • Table 122: Global Gastric Cancer Drugs Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Table 123: Merck & Co. Inc. –  Financial Overview, 2016 - 2020, $ Billion
    • Table 124: Sanofi SA – Financial Overview, 2016 - 2020, $ Billion
    • Table 125: Pfizer Inc. – Financial Overview, 2016 - 2020, $ Billion
    • Table 126: AstraZeneca – Financial Overview, 2016 - 2020, $ Billion
    • Table 127: Global Pediatric Vaccine Market, Product Pipeline Analysis
    • Table 128: Global Pediatric Vaccine Market Size Gain ($ Million), 2020 – 2025, By Country
    • Table 129: Global Pediatric Vaccine Market Size Gain ($ Million), Segmentation By Vaccine Type, 2020 – 2025
    • Table 130: Global Pediatric Vaccine Market Size Gain ($ Million), Segmentation By Technology, 2020 – 2025
    • Table 131: Global Pediatric Vaccine Market Size Gain ($ Million), Segmentation By Application, 2020 – 2025

    List Of Figures

      Figure 1: Global Pediatric Vaccine Market Segmentation By Vaccine Type
    • Figure 2: Global Pediatric Vaccine Market Segmentation By Technology
    • Figure 3: Global Pediatric Vaccine Market Segmentation By Application
    • Figure 4: Global Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 5: Global Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 6: Global Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 7: Global Pediatric Vaccine Market, Segmentation By Technology, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 8: Global Pediatric Vaccine Market, Segmentation By Application, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 9: Global Pediatric Vaccine Market, By Region, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 10: Global Pediatric Vaccine Market, By Country, Historic and Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 11: Asia-Pacific Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 12: Asia-Pacific Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 13: Asia-Pacific Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 14: China Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 15: China Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 16: China Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 17: India Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 18: India Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 19: India Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 20: Japan Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 21: Japan Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 22: Japan Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 23: Australia Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 24: Australia Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 25: Australia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 26: Indonesia Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 27: Indonesia Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 28: Indonesia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 29: South Korea Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 30: South Korea Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 31: South Korea Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 32: Western Europe Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 33: Western Europe Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 34: Western Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 35: UK Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 36: UK Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 37: UK Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 38: Germany Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 39: Germany Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 40: Germany Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 41: France Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 42: France Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 43: France Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 44: Eastern Europe Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 45: Eastern Europe Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 46: Eastern Europe Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 47: Russia Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 48: Russia Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 49: Russia Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 50: North America Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 51: North America Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 52: North America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 53: USA Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 54: USA Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 55: USA Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 56: South America Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 57: South America Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 58: South America Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 59: Brazil Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 60: Brazil Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 61: Brazil Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 62: Middle East Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 63: Middle East Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 64: Middle East Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 65: Africa Pediatric Vaccine Market, Historic, 2015 – 2020, $ Million
    • Figure 66: Africa Pediatric Vaccine Market, Forecast, 2020 – 2025, 2030F, $ Million
    • Figure 67: Africa Pediatric Vaccine Market, Segmentation By Vaccine Type, Historic And Forecast, 2015 – 2020, 2025F, 2030F, %
    • Figure 68: Global Pediatric Vaccine Market, Key Competitor Estimated Market Shares, 2020, Percentage (%)
    • Figure 69: Merck & Co. Inc. – Financial Overview 2016 –  2020, $ Billion
    • Figure 70: Sanofi SA – Financial Overview, 2016 – 2020, $ Billion
    • Figure 71: Pfizer Inc. – Financial Overview, 2016 – 2020, $ Billion
    • Figure 72: AstraZeneca – Financial Overview, 2016 – 2020, $ Billion
    Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Psoriatic Arthritis Treatment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Regenerative Medicine For Cartilage Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Radiopharmaceuticals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Research Antibodies and Reagents Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Rituximab Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Global Respiratory Diseases Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
    Dry Eye Medication Market - By Prescription Type (OTC Drugs, Prescription Drugs) By Drug Variation (Branded, Generic) By Type Of Product (Aqueous, Evaporative, Aqueous and Evaporative) By Distribution Channel (Hospital Pharmacies, Eye Health Clinics, Retail Pharmacies, Online Pharmacies) By Delivery System (Liquid, Gel, Ointment, Others) And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Ophthalmology Drugs Market - By Type (Antglaucoma Drugs, Dry Eye Medication And Other Ophthalmological Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies/ Drug Stores And Others), By Drug Classification (Branded Drugs And Generic Drugs), By Mode Of Purchase (Prescription-Based Drugs, Over-The-Counter Drugs) And, By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Pharmaceutical Drugs Market - By Segments (Musculoskeletal Disorders Drugs, Cardiovascular Drugs, Oncology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Central Nervous System Drugs, Genito-Urinary Drugs, Respiratory Diseases Drugs, Gastrointestinal Drugs, Hematology Drugs, Dermatology Drugs, Ophthalmology Drugs), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Musculoskeletal Drugs Market Global Briefing 2018
    View Report
    Respiratory Drugs Market Global Briefing 2018
    View Report
    Antisense And RNAi Therapeutics Market- By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease, Other diseases), And By Region, Opportunities And Strategies – Global Forecast To 2030
    View Report
    Diabetes Therapies Market - By Segments (Injectables And Oral), Trends, Key Players, Opportunities And Strategies – Global Forecast To 2023
    View Report
    Global Biologics Market - By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), By Route Of Administration (Oral, Others (IV or IP)), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2023
    View Report

    Call Us

    +1 3156230293

    (Americas)

    +44 2071930708

    (Europe)

    +91 8897263534

    (Asia & Others)